Clinical Trials for Sanofi-Synthelabo

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sanofi-Synthelabo

Clinical Trials (1)

NCT04975152
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
PHASE1Active, not recruiting
36 participants
Started: Oct 22, 2021 · Completed: Mar 31, 2028
2 conditions3 sponsors1 location